Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.
A new compound aims to attack dangerous antibiotic-resistant bacteria.
Our Global Head of Patient Affairs and Policy shares why it’s critical to engage patients throughout the drug development process.
A diminutive protein prompts a closer look at DNA dark matter.
Marc Pelletier traveled from Cambridge, MA to Shanghai, China, to launch new lines of research for the treatment of cancers that are common in China.
Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.
Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success
Learn how Novartis is using technology to improve the oncology clinical trial process.